Peak6 Investments LLC Bristol Myers Squibb CO Call Options Transaction History

Peak6 Investments LLC

$43.5 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $8.55 Million - $11.2 Million	215,500 Added 686.31%	246,900 $12.8 Million
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $217,350 - $286,146	5,400 Added 20.77%	31,400 $1.3 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $47,980 - $54,400	1,000 Added 4.0%	26,000 $1.41 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $2.42 Million - $2.89 Million	-50,000 Reduced 66.67%	25,000 $1.28 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $2.5 Million - $2.8 Million	43,200 Added 135.85%	75,000 $4.35 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $1.76 Million - $1.95 Million	-27,600 Reduced 46.46%	31,800 $2.03 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $41.6 Million - $47.1 Million	-632,500 Reduced 91.41%	59,400 $4.12 Million
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $31.1 Million - $36.8 Million	454,100 Added 190.96%	691,900 $49.8 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $140,426 - $83 Million	-1,080,200 Reduced 81.96%	237,800 $16.9 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $55.9 Million - $61.5 Million	-769,500 Reduced 36.86%	1,318,000 $101 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $69.9 Million - $83.8 Million	1,136,200 Added 119.44%	2,087,500 $152 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $33.4 Million - $38.9 Million	623,000 Added 189.77%	951,300 $59.3 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $3.41 Million - $4 Million	-57,700 Reduced 14.95%	328,300 $19.4 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $13.3 Million - $14.5 Million	215,200 Added 126.0%	386,000 $25.8 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $32.4 Million - $36.4 Million	-545,600 Reduced 76.16%	170,800 $10.8 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $7.7 Million - $8.72 Million	-133,300 Reduced 15.69%	716,400 $44.4 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $9.4 Million - $10.4 Million	-163,600 Reduced 16.15%	849,700 $51.2 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $2.6 Million - $3.04 Million	-47,400 Reduced 4.47%	1,013,300 $59.6 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $45 Million - $65.4 Million	970,600 Added 1077.25%	1,060,700 $59.1 Million
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $14.8 Million - $19.2 Million	-299,800 Reduced 76.89%	90,100 $5.78 Million
Q3 2019 Nov 08, 2019	BUY	$42.77 - $50.71 $13.1 Million - $15.5 Million	305,300 Added 360.87%	389,900 $19.6 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $2.78 Million - $3.07 Million	-62,300 Reduced 42.41%	84,600 $3.84 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $6.43 Million - $7.67 Million	-142,600 Reduced 49.26%	146,900 $7.01 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $5.29 Million - $6.86 Million	108,500 Added 59.94%	289,500 $15 Million
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $9.99 Million - $11.3 Million	181,000 New	181,000 $11.2 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.9 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.16 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.37 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.5 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.53 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Account